Drug application
LO LARIN FE (ETHINYL ESTRADIOL, NORETHINDRONE ACETATE)
Drugs@FDA ANDA 208661 · NOVAST LABS LTD
Key facts
| Drug name | LO LARIN FE |
|---|---|
| Active ingredients | ETHINYL ESTRADIOL, NORETHINDRONE ACETATE |
| Application type | ANDA |
| Application number | 208661 |
| Company | NOVAST LABS LTD |
| Dosage forms | TABLET, ORAL |
| Strength | 0.01MG,0.01MG;1MG,N/A |
| Marketing status | None (Tentative Approval) |
| Reference listed drug | No |
| Latest submission status date | Dec 20, 2016 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.